Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis
- PMID: 23900314
- DOI: 10.1136/bmj.f4533
Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis
Abstract
Objectives: To provide a systematic and quantitative summary of the association between severe hypoglycaemia and risk of cardiovascular disease in people with type 2 diabetes and to examine the sensitivity of the association to possible uncontrolled confounding by unmeasured comorbid severe illness using a bias analysis.
Design: Meta-analysis of observational studies.
Data sources: Medline, Embase, the Cochrane Library, and Web of Science databases were searched to February 2013, without any language restrictions.
Eligibility criteria: Two independent reviewers selected cohort studies that evaluated the association of severe hypoglycaemia with cardiovascular events in people with type 2 diabetes; we excluded studies from acute hospital settings. We extracted descriptive and quantitative data.
Results: Of 3443 citations screened, six eligible studies with 903, 510 participants were identified. In the conventional random effects meta-analysis, severe hypoglycaemia was strongly associated with a higher risk of cardiovascular disease (relative risk 2.05, 95% confidence interval 1.74 to 2.42; P<0.001). The excess fraction of cardiovascular disease incidence that was attributable to severe hypoglycaemia (the population attributable fraction) was 1.56% (95% confidence interval 1.32% to 1.81%; P<0.001). Although moderate heterogeneity across the studies was suggested (I(2)=73.1%; P=0.002 for heterogeneity), most subgroups showed similar results in stratified analyses. The bias analysis indicated that comorbid severe illness alone may not explain the association between hypoglycaemia and cardiovascular disease; to explain this association, comorbid severe illness would have had to be extremely strongly associated with both severe hypoglycaemia and cardiovascular disease.
Conclusion: Our findings suggest that severe hypoglycaemia is associated with a higher risk of cardiovascular disease; they also support the notion that avoiding severe hypoglycaemia may be important to prevent cardiovascular disease in people with type 2 diabetes.
Comment in
-
Diabète: attention aux hypoglycémies sévères car elles augmentent le risque cardiovasculaire.Rev Prat. 2013 Sep;63(7):924. Rev Prat. 2013. PMID: 24167889 French. No abstract available.
Similar articles
-
Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies.PLoS One. 2015 Jun 10;10(6):e0126427. doi: 10.1371/journal.pone.0126427. eCollection 2015. PLoS One. 2015. PMID: 26061690 Free PMC article. Review.
-
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.Cochrane Database Syst Rev. 2013 Nov 11;(11):CD008143. doi: 10.1002/14651858.CD008143.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2015 Jul 29;(7):CD008143. doi: 10.1002/14651858.CD008143.pub4 PMID: 24214280 Updated. Review.
-
Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: A systematic review and meta-analysis.Diabetes Obes Metab. 2018 Sep;20(9):2169-2178. doi: 10.1111/dom.13348. Epub 2018 May 31. Diabetes Obes Metab. 2018. PMID: 29740922
-
Bi-directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose-lowering agents: a systematic review and meta-analysis.Diabetes Obes Metab. 2016 Feb;18(2):135-41. doi: 10.1111/dom.12587. Epub 2015 Dec 8. Diabetes Obes Metab. 2016. PMID: 26446922 Review.
-
Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: A systematic review and meta-analysis.Diabetes Res Clin Pract. 2020 Dec;170:108522. doi: 10.1016/j.diabres.2020.108522. Epub 2020 Oct 21. Diabetes Res Clin Pract. 2020. PMID: 33096187
Cited by
-
Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).Front Endocrinol (Lausanne). 2024 Oct 21;15:1412553. doi: 10.3389/fendo.2024.1412553. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39497800 Free PMC article. Clinical Trial.
-
Major adverse cardiovascular events' reduction and their association with glucose-lowering medications and glycemic control among patients with type 2 diabetes: A retrospective cohort study using electronic health records.J Diabetes. 2024 Oct;16(10):e13604. doi: 10.1111/1753-0407.13604. J Diabetes. 2024. PMID: 39431844 Free PMC article.
-
Decline in use of high-risk agents for tight glucose control among older adults with diabetes in New York City: 2017-2022.J Am Geriatr Soc. 2024 Sep;72(9):2721-2729. doi: 10.1111/jgs.19060. Epub 2024 Jul 9. J Am Geriatr Soc. 2024. PMID: 38980267
-
Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes.Diabetes Ther. 2024 Aug;15(8):1657-1672. doi: 10.1007/s13300-024-01607-5. Epub 2024 Jun 22. Diabetes Ther. 2024. PMID: 38907936 Free PMC article.
-
Cardiometabolic Risk Factors among Women with Eating Disorders in Saudi Arabia.J Nutr Metab. 2024 Jun 5;2024:5953893. doi: 10.1155/2024/5953893. eCollection 2024. J Nutr Metab. 2024. PMID: 38867850 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical